EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and validation of bile exosomal microRNA signatures for diagnosing acute rejection in liver transplant recipients

Wenjing Wang, Hui Wang, Wen Li, Renchi Fu, Bo Wang, Bo Guo

Frontiers in Genetics · 29.06.2026 · 17

DOI: 10.3389/fgene.2026.1877181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 29.06.2026. Verfasst von Wenjing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Intensive Care Unit, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute rejection (AR) remains a major complication affecting graft function and recipient prognosis after liver transplantation (LT). Bile exosomal microRNAs (miRNAs) possess organ specificity, local enrichment, and high stability, making them promising non-invasive liquid biopsy biomarkers for the early detection of AR.

Methods

In this study, bile samples were collected from 30 LT recipients with AR and 30 recipients with stable graft function (non-AR). Exosomes were isolated via ultracentrifugation and characterized. Total RNA was extracted and subjected to small RNA sequencing, followed by bioinformatics analysis. Candidate differentially expressed miRNAs were then validated using Real-Time Quantitative PCR (qRT-PCR) in an expanded cohort.

Results

Sequencing revealed 63 significantly upregulated and 4 downregulated miRNAs in the AR group compared with the non-AR group. Target genes of candidate differentially expressed miRNAs were enriched in key immune-regulatory pathways, including PI3K-Akt and MAPK signaling. qRT-PCR validation further confirmed that the expression levels of miR-181a-5p, miR-200c-3p, and miR-192-5p in bile exosomes were significantly higher in the AR group (P < 0.0001).

Discussion

Our findings identify and validate bile exosomal miRNA signatures for AR in LT recipients, supporting these miRNAs as a low-risk, organ-specific liquid biopsy strategy for AR diagnosis, with potential for clinical translation in post-transplant monitoring.

Schlagwörter

Stichwörter der Autor:innen

acute rejectionbileexosomesliver transplantationmiRNA

Autor:innen und Institutionen

  • Surgical Intensive Care Unit, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Zitieren

APA

Wang, W., Wang, H., Li, W., Fu, R., Wang, B., & Guo, B. (2026). Identification and validation of bile exosomal microRNA signatures for diagnosing acute rejection in liver transplant recipients. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1877181

Vancouver

Wang W, Wang H, Li W, Fu R, Wang B, Guo B. Identification and validation of bile exosomal microRNA signatures for diagnosing acute rejection in liver transplant recipients. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1877181

BibTeX
@article{Wang2026,
  author = {Wang, Wenjing and Wang, Hui and Li, Wen and Fu, Renchi and Wang, Bo and Guo, Bo},
  title = {Identification and validation of bile exosomal microRNA signatures for diagnosing acute rejection in liver transplant recipients},
  journal = {Frontiers in Genetics},
  year = {2026},
  volume = {17},
  doi = {10.3389/fgene.2026.1877181}
}
Kostenlos starten →